🚀 Biomanufacturing breakthrough: Using our AI-powered, cell-free exozyme platform, we’ve gone from concept to gram-scale NCT in only 5 months!

Co-founder and VP of Development at eXoZymes, Dr. Paul Opgenorth, states,

"Going from the original proof-of-concept to lab scale validation, our goal was to make a first version of a biosolution that can produce at least one gram of NCT per batch, which we now have delivered on with an impressive 96% reaction yield. Not only does this biomanufacturing breakthrough prove the technical proficiency of our platform - but we have also accomplished this in only 5 months and with a limited budget. A timeline that’s unheard of in SynBio or anywhere, really.”

This isn’t just a milestone for NCT - it’s a validation of our 'powered by eXoZymes' biosolution platform that can unlock 100s of valuable natural products.

📽️ Full story here: https://exozymes.com/blog/nct-breakthrough-paul

👉 Early access partnerships now open: https://exozymes.com/partners